Trial Profile
A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Jan 2021
Price :
$35
*
At a glance
- Drugs Sertraline (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Sponsors Pfizer
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2012 Planned End Date changed from 1 Oct 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 14 Aug 2012 Planned initiation date changed from 1 Jul 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.